Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation

NCT01871376 is registered in ClinicalTrials.gov with Gregg T. Kokame, MD as lead sponsor.

NCT NCT01871376
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01871376 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
Lead sponsor
Gregg T. Kokame, MD
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2013
Completion date
September 30, 2016
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polypoidal choroidal vasculopathy